COMPOSITIONS AND METHODS FOR SILENCING MYOC EXPRESSION

The disclosure relates to double-stranded ribonucleic acid (dsRNA) compositions targeting MYOC, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of MYOC. L'invention concerne des compositions d'acide ribonucléique double brin (ARNdb) ciblant MYOC, et des pro...

Full description

Saved in:
Bibliographic Details
Main Authors JADHAV, Vasant R, CASTELLANOS-RIZALDOS, Elena, CASTORENO, Adam, PANDYA, Bhaumik A, SCHLEGEL, Mark K
Format Patent
LanguageEnglish
French
Published 05.01.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The disclosure relates to double-stranded ribonucleic acid (dsRNA) compositions targeting MYOC, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of MYOC. L'invention concerne des compositions d'acide ribonucléique double brin (ARNdb) ciblant MYOC, et des procédés d'utilisation de telles compositions d'ARNdb pour modifier (par exemple, inhiber) l'expression de MYOC.
Bibliography:Application Number: WO2022US35266